Filtros de búsqueda

Lista de obras de Tim M. Illidge

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

artículo científico publicado en 2014

944OBRENTUXIMAB VEDOTIN IN COMBINATION WITH CHP IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED CD30+ PERIPHERAL T-CELL LYMPHOMAS (PTCL): 2-YEAR FOLLOW-UP

artículo científico publicado en 2014

A New in Vivo and in Vitro B cell Lymphoma Model, π-BCL1

article

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

artículo científico publicado en 2016

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells

artículo científico publicado en 2004

A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

artículo científico publicado en 2014

A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies

artículo científico publicado en 2010

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

scientific article published on 17 October 2013

Abstract 3042: The novel Akt inhibitor AZD5363 following radiotherapy improves tumor control in mouse models of head and neck cancer

Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade

artículo científico publicado en 2014

Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment

artículo científico publicado en 2017

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

artículo científico publicado en 2015

Anti-CD 40 monoclonal antibody.

artículo científico publicado en 2005

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma

artículo científico publicado en 2003

Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature.

artículo científico publicado en 2001

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

artículo científico publicado en 2003

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

artículo científico publicado en 2012

Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells

artículo científico publicado en 2016

Apparent modulation of CD20 by rituximab: an alternative explanation

artículo científico publicado en 2004

Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?

artículo científico publicado en 2015

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

artículo científico publicado en 2013

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study

artículo científico publicado en 2012

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study

artículo científico publicado en 2017

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

artículo científico publicado en 2012

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study

artículo científico publicado en 2014

British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

artículo científico publicado en 2018

Cervical Neuropathy Following Mantle Radiotherapy

scientific article published on 01 December 2002

Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas

artículo científico publicado en 2014

Clinical Development of Novel Drug-Radiotherapy Combinations

artículo científico publicado en 2018

Clinical development of new drug-radiotherapy combinations ⬇️

artículo científico publicado en 2016

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

artículo científico publicado en 2007

Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling

artículo científico

Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)".

artículo científico publicado en 2014

Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma

artículo científico publicado el 1 de diciembre de 2012

Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop

artículo científico publicado en 2008

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

scientific article published on 01 March 2020

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Current Developments in Specialty Training

artículo científico publicado en 2011

Current treatment approaches for diffuse large B-cell lymphoma

artículo científico publicado en 2008

Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells

artículo científico publicado en 2005

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

artículo científico publicado en 2013

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation

artículo científico publicado en 2007

Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy

artículo científico

Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks

artículo científico publicado en 2003

Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase

artículo científico publicado en 2008

Euthanasia

scientific article published in the British Medical Journal

Evaluation of apoptosis imaging biomarkers in a genetic model of cell death

artículo científico publicado en 2019

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 04 July 2016

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).

artículo científico publicado en 2014

Five-Year Outcomes for Frontline Brentuximab Vedotin with CHP for CD30 Expressing Peripheral T-Cell Lymphomas

artículo científico publicado en 2018

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

artículo científico publicado en 2017

Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade

artículo científico publicado en 2017

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

artículo científico publicado en 2013

Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer

artículo científico publicado en 2007

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

artículo científico publicado en 2013

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

scientific article published on 19 July 2011

Guidelines on the investigation and management of follicular lymphoma

artículo científico publicado en 2011

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

artículo científico publicado en 2014

How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?

artículo científico publicado en 2018

How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?

scientific article published on July 2008

ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic

scientific article published on 10 April 2020

Immune Checkpoint Inhibitors in Lung Cancer - An Unheralded Opportunity?

artículo científico publicado en 2017

Immuno-regulatory antibodies for the treatment of cancer

artículo científico

Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations

artículo científico publicado en 2013

Immunotherapy with radiotherapy in urological malignancies

artículo científico publicado en 2016

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy

artículo científico publicado en 2016

Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines

scientific article published on 06 April 2020

Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?

scientific article published on 18 June 2020

Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate

scientific article published on 01 January 1996

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

scientific article published on 01 January 2020

Methodological Considerations in the Evaluation of Radiotherapy Technologies

scientific article published on 12 July 2012

Microscopic Intratumoral Dosimetry of Radiolabeled Antibodies Is a Critical Determinant of Successful Radioimmunotherapy in B-Cell Lymphoma

artículo científico publicado en 2007

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

artículo científico

Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group

artículo científico publicado en 2015

Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group

artículo científico publicado en 2014

Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group

artículo científico publicado en 2015

Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

artículo científico publicado en 1998

New antibody drug treatments for lymphoma

scientific article published on 14 March 2011

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

artículo científico publicado en 2008

New opportunities for anti-CD20 monoclonal antibody to give a direct punch to the tumor

artículo científico publicado en 2013

Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma

scientific article published on 31 March 2019

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

artículo científico publicado en 2011

Nuclear envelope-limited chromatin sheets are part of mitotic death

artículo científico publicado en 2002

Obinutuzumab (GA101) – a different anti-CD20 antibody with great expectations

artículo científico publicado en 2012

Obinutuzumab in hematologic malignancies: lessons learned to date

artículo científico publicado en 2015

PET-Directed Therapy for Hodgkin's Lymphoma

artículo científico publicado en 2015

Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.

artículo científico publicado en 2018

Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial.

artículo científico publicado en 2018

Personalised approach to treating early Hodgkin's lymphoma

artículo científico publicado en 2015

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

artículo científico publicado en 2008

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma

artículo científico publicado en 2013

Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage.

artículo científico publicado en 2000

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

scientific article published on 21 May 2019

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

artículo científico publicado en 2022

Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group

artículo científico publicado en 2015

Radiation therapy with tositumomab (B1) anti-CD20 monoclonal antibody initiates extracellular signal-regulated kinase/mitogen-activated protein kinase-dependent cell death that overcomes resistance to apoptosis

artículo científico publicado en 2008

Radiation-induced apoptosis

artículo científico publicado en 1998

Radioimmunotherapy in follicular lymphoma

artículo científico publicado en 2011

Radioimmunotherapy in the π-BCL1 B cell Lymphoma Model: Efficacy Depends on More Than Targeted Irradiation Alone

article

Radioimmunotherapy of Lymphoma: A Treatment Approach Ahead of Its Time or Past Its Sell-By Date?

artículo científico publicado en 2010

Radiotherapy Research Priorities for the UK

artículo científico publicado en 2010

Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

artículo científico publicado en 2016

Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms

artículo científico publicado en 2017

Radiotherapy physics research in the UK: challenges and proposed solutions.

artículo científico publicado en 2012

Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany

artículo científico publicado en 2017

Recommendations for the clinical management of the elderly patient with malignant lymphoma.

artículo científico publicado en 2018

Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.

artículo científico publicado en 2006

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

scientific article published on 12 June 2011

Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line..

artículo científico publicado en 2000

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

artículo científico publicado en 2020

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma

artículo científico publicado en 2015

Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity

artículo científico publicado en 2018

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

artículo científico publicado en 2018

Segregation of genomes in polyploid tumour cells following mitotic catastrophe.

artículo científico publicado en 2005

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.

artículo científico

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

artículo científico publicado en 2016

Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response

artículo científico publicado en 2013

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

artículo científico publicado en 2013

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma

artículo científico publicado en 2012

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

The Junior Radiology Forum: What do the trainees think about the future of oncology training?

artículo científico publicado en 1998

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group

artículo científico publicado en 2018

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

artículo científico publicado en 2015

The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer

artículo científico publicado en 2017

The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

artículo científico publicado en 2015

The effect of hypoxia on PD-L1 expression in bladder cancer

artículo científico publicado en 2021

The future of anti-CD20 monoclonal antibodies: are we making progress?

scientific article published on 05 January 2011

The future of oncology training: from the trainees' perspective

artículo científico publicado en 1998

The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma

article

The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab

artículo científico publicado en 2013

The influence of radiation in the context of developing combination immunotherapies in cancer

artículo científico publicado en 2017

The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper

artículo científico publicado en 2019

Tumor cell embryonality and the ploidy number 32n: is it a developmental checkpoint?

artículo científico publicado en 2011

Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy

artículo científico publicado en 2015

U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

artículo científico publicado en 2012

Update on obinutuzumab in the treatment of B-cell malignancies

artículo científico

Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects

artículo científico publicado en 2010

When is a predose a dose too much?

scientific article published on 01 June 2009

XVII. Radiotherapy in early stage Hodgkin lymphoma ⬇️

artículo científico publicado el 1 de junio de 2013

YY1 expression predicts favourable outcome in follicular lymphoma

scientific article published on 25 November 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda